Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158387 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paola Galozzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Unit, Department of Medicine DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy. Hauptthemen laut MEDLINE: Tears, Biomarkers, Uveitis, Arthritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blau syndrome (BS) is a rare autoinflammatory granulomatosis characterized by granulomatous arthritis, uveitis, and dermatitis. Ocular complications are particularly severe in BS, significantly contributing to morbidity. This study aims to identify potential biomarkers for BS ocular degeneration through proteomic profiling of tear samples from affected patients. Seven subjects from the same family, including four carriers of the BS-associated NOD2 mutation (p.E383K), were recruited alongside healthy controls. Tear samples were collected using Schirmer strips and analyzed via mass spectrometry. A total of 387 proteins were identified, with significant differences in protein expression between BS patients, healthy familial subjects, and healthy controls. Key findings include the overexpression of alpha-2-macroglobulin (A2M) and immunoglobulin heavy constant gamma 4 (IGHG4) in BS patients. Bioinformatic analysis revealed that differentially expressed proteins are involved in acute-phase response, extracellular exosome formation, and protein binding. Notably, neutrophils’ azurophilic granule components, as azurocidin (AZU1), myeloperoxidases (MPO), and defensins (DEFA3), were highly expressed in the most severely affected subject, suggesting a potential role of neutrophils in BS ocular severity. These proteins might be promising biomarkers for ocular involvement in BS, facilitating early detection and tailored treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine Unit, Department of Medicine DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
- Rheumatology Unit, Department of Medicine DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
- Department of Biomedical Sciences, University of Padova, 35128 Padova, Italy.
- Ophthalmology Unit, Department of Neuroscience, University of Padova, 35128 Padova, Italy.
ORCID-Profile: Paola Galozzi, Ilaria Battisti, Andrea Leonardi, Daniela Basso, Giorgio Arrigoni, Paolo Sfriso
Zitieren
APA
Galozzi, P., Bindoli, S., Baggio, C., Battisti, I., Leonardi, A., Basso, D., Arrigoni, G., & Sfriso, P. (2024). Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158387
Vancouver
Galozzi P, Bindoli S, Baggio C, Battisti I, Leonardi A, Basso D, et al. Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158387
BibTeX
@article{Galozzi2024,
author = {Galozzi, Paola and Bindoli, Sara and Baggio, Chiara and Battisti, Ilaria and Leonardi, Andrea and Basso, Daniela and Arrigoni, Giorgio and Sfriso, Paolo},
title = {Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158387}
}
EUVIMED